Pharmacokinetics of the peripheral benzodiazepine receptor antagonist, PK 11195, in rats. The effect of dose and gender.

In spite of the extensive use of the peripheral benzodiazepine (BZ) receptor antagonist, PK 11195 (PK), in pharmacological studies, there is a lack of information of its pharmacokinetics in the rat. In this study the pharmacokinetics of PK were determined after bolus intravenous (i.v.) administration in rat. The effects of dose and gender were evaluated in Sprague-Dawley age-matched male and female rats after the injection of PK (5, 10, 20 mg kg(-1)). Plasma was collected at 5-300 min. Levels of PK in plasma and brain were determined by a novel HPLC method. The stability of PK in blood in vitro was determined. PK is stable in rat blood in vitro. The pharmacokinetics of PK are described by a two-compartment model. The half-lives for distribution ( approximately 0.14 h) and elimination ( approximately 5.4 h) are not related to dose. The large volume of distribution (9-24 l kg(-1)) indicates an extensive distribution outside plasma. Total plasma clearance increases with increasing dose (23-42 ml min(-1)kg(-1)). The brain/plasma ratio ( approximately 3) is not related to dose. These finding suggest that the pharmacokinetics of PK are related to dose (5-20 mg kg(-1)) and gender in rat.

[1]  J. Sloan,et al.  Diazepam-Treated Female Rats Flumazenil- and PK 11195-Induced Withdrawal in the Hippocampus CA1 , 1998, Pharmacology Biochemistry and Behavior.

[2]  M. Gavish,et al.  Peripheral-type benzodiazepine receptor ligands and serum steroid hormones , 1997, Brain Research.

[3]  J. Sloan,et al.  Comparison of abstinence syndromes precipitated by flumazenil and PK 11195 in female diazepam-dependent rats , 1997, Psychopharmacology.

[4]  R. S. Leeuwin,et al.  The benzodiazepine receptor antagonist PK 11195 alters diazepam-induced changes of tetanic contractions in the rat phrenic nerve-diaphragm preparation , 1997 .

[5]  T. Kumai,et al.  Effects of the estrous cycle and the gender differences on hepatic drug-metabolising enzyme activities. , 1997, Pharmacological research.

[6]  J. Sloan,et al.  Intrathecally administered flumazenil and PK 11195 precipitate abstinence syndrome in freely moving diazepam dependent rats. , 1996, Drug and alcohol dependence.

[7]  J. Sloan,et al.  Precipitated abstinence in the diazepam-dependent rat , 1993, Pharmacology Biochemistry and Behavior.

[8]  L. Buéno,et al.  Physical dependence on diazepam: Precipitation of abstinence syndromes by peripheral and central benzodiazepine receptor antagonists , 1992, Pharmacology Biochemistry and Behavior.

[9]  E. O. Johnson,et al.  Effects of peripheral benzodiazepine receptor ligands on hypothalamic-pituitary-adrenal axis function in the rat. , 1990, The Journal of pharmacology and experimental therapeutics.

[10]  M. Massotti,et al.  Involvement of the “peripheral” benzodiazepine receptor type (ω 3) in the tolerance to the electroencephalographic effects of benzodiazepines in rats: Comparison of diazepam and clonazepam , 1990, Pharmacology Biochemistry and Behavior.

[11]  B. Lecocq,et al.  PHARMACOKINETICS AND EFFECTS ON EXERCISE HEART RATE OF PK 11195 (52028 RP), AN ANTAGONIST OF PERIPHERAL BENZODIAZEPINE RECEPTORS, IN HEALTHY VOLUNTEERS , 1989, Fundamental & clinical pharmacology.

[12]  M. Woodruff,et al.  Free Drug Concentration Monitoring in Clinical Practice , 1986 .

[13]  W. Ziegler,et al.  Pharmacokinetics of the new benzodiazepine antagonist Ro 15-1788 in man following intravenous and oral administration. , 1986, British journal of clinical pharmacology.

[14]  S. File,et al.  The effects of PK 11195, a ligand for benzodiazepine binding sites, in animal tests of anxiety and stress , 1985, Pharmacology Biochemistry and Behavior.

[15]  J. Bénavidès,et al.  In vivo labelling in several rat tissues of 'peripheral type' benzodiazepine binding sites. , 1984, European journal of pharmacology.

[16]  S. File,et al.  Pharmacokinetic studies on Ro 15-1788, a benzodiazepine receptor ligand, in the brain of the rat , 1984, Brain Research.

[17]  G. Fur,et al.  Labelling of “Peripheral‐Type” Benzodiazepine Binding Sites in the Rat Brain By Using [3H]PK 11195, an Isoquinoline Carboxamide Derivative: Kinetic Studies and Autoradiographic Localization , 1983, Journal of neurochemistry.

[18]  G. Le Fur,et al.  Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide. I. In vitro studies. , 1983, Life sciences.

[19]  S. Ojeda,et al.  A rapid and simple procedure for chronic cannulation of the rat jugular vein. , 1974, Journal of applied physiology.

[20]  M. Ansseau,et al.  Pilot Study of PK 11195, a Selective Ligand for the Peripheral-Type Benzodiazepine Binding Sites, in Inpatients with Anxious or Depressive Symptomatology , 1991, Pharmacopsychiatry.

[21]  Malcolm Rowland,et al.  Clinical pharmacokinetics : concepts and applications , 1989 .

[22]  D. Greenblatt,et al.  Age and gender effects on chlordiazepoxide kinetics: relation to antipyrine disposition. , 1989, Pharmacology.